TPC enters the final weeks of Q3 with the most consequential story happening not in the market but in the SEC filing record — the company's founder and largest individual shareholder has been aggressively reducing his stake, raising questions about conviction at the top even as the construction backlog remains strong.
The headline is hard to ignore. Ronald Tutor sold roughly 2.31 million shares on August 31 alone, at prices around $85–$90, generating approximately $197 million in proceeds across two transactions. Those sales were discretionary — no 10b5-1 plan was in place. His stake has dropped from 12.4% to 8.2% per the most recent Schedule 13D/A filed September 2, and the institutional ownership table confirms his remaining holding at around 4.07 million shares, down by 2.31 million in the most recent reported period. At the same time, director Sidney Feltenstein sold a combined 184,209 shares across four transactions on August 7, netting over $17.8 million, also without a pre-arranged trading plan. Net insider selling over the past 90 days totals nearly 2.5 million shares, worth roughly $217 million. That is a concentrated, discretionary exit by the people closest to the business.
The ownership picture has a counter-current worth noting. BlackRock added 2.69 million shares in its most recently reported period, lifting its stake to 12.8% of the company — now the largest institutional holder and up from 7.3% previously. American Century added 502,000 shares, First Trust added 454,000, and State Street added 416,000. Capital Research and Management built a position of 4.3% as of June. The passive and institutional bid has been absorbing what the insiders are selling, which helps explain why the stock, despite the heavy insider pressure, has held relatively close to those transaction prices. TPC closed at $85.77 on September 22, down only about 6% over the past month.
Short positioning tells a relaxed story that provides little additional drama. Short interest runs at 3.9% of the free float — modest by any measure. It drifted roughly flat over the past week, down less than 1% week-on-week after declining about 3% over the past month. The borrow market is extremely loose: availability is running above 1,660%, meaning shares to borrow vastly outnumber those already borrowed. Cost to borrow has ticked up 29% over the past week but remains at just 0.54% annualised — well within the range of any generalist who wants to put on a short position cheaply. The ORTEX short score of 38 sits in the lower-middle of the range, consistent with a stock where short interest is present but not particularly charged. Options positioning is similarly benign: the put/call ratio of 0.50 is marginally below its 20-day average of 0.51, and the z-score of -0.75 suggests no unusual demand for downside protection.
On the Street, the analyst picture is constructive but the most recent data is about seven weeks old. UBS raised its target to $105 from $98 on August 6, maintaining its Buy rating — the fourth consecutive target lift from that desk since mid-2025, tracking TPC's run from the $40s. The consensus mean target sits at $116.25, implying roughly 36% upside from current levels. Valuation multiples have been drifting lower: the PE has compressed by about 0.6 turns over the past 30 days to 14.6x, and EV/EBITDA has eased to 7.7x. Those are not stretched multiples for a construction name with a robust backlog, and the price-to-book of 2.5x reflects the market's recognition of improving earnings quality. Factor scores are mixed: the dividend score ranks in the 91st percentile (the last actual dividend was paid in 2010, so this likely reflects yield-related metrics rather than an active payment), while EPS forward growth ranks in just the 28th percentile, consistent with the recent note flagging stalling estimate upgrades.
Earnings history adds one more dimension. The two most recent prints produced one-day moves of +17% and +12% respectively, with five-day follow-throughs of +12% in both cases. The next event is scheduled for November 5. With the stock now trading about 12% below the post-earnings peak in early August, the gap between the current price and the UBS $105 target, and the contrast between heavy insider selling and a strengthening institutional register, the November print becomes the clearest near-term test of whether the backlog strength the bulls are pricing translates into the margin improvement the Street has been waiting for.
See the live data behind this article on ORTEX.
Open TPC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
